BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25422486)

  • 1. Dilemmas in treating smoldering multiple myeloma.
    Ahn IE; Mailankody S; Korde N; Landgren O
    J Clin Oncol; 2015 Jan; 33(1):115-23. PubMed ID: 25422486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics.
    Sundararajan S; Kumar A; Korde N; Agarwal A
    Curr Hematol Malig Rep; 2016 Apr; 11(2):102-10. PubMed ID: 26894382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
    Caers J; Fernández de Larrea C; Leleu X; Heusschen R; Zojer N; Decaux O; Kastritis E; Minnema M; Jurczyszyn A; Beguin Y; Wäsch R; Palumbo A; Dimopoulos M; Mateos MV; Ludwig H; Engelhardt M
    Oncologist; 2016 Mar; 21(3):333-42. PubMed ID: 26921288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding high-risk smoldering multiple myeloma.
    Kreiniz N; Gertz MA
    Leuk Lymphoma; 2023; 64(8):1361-1372. PubMed ID: 37229535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoldering multiple myeloma.
    Rajkumar SV; Landgren O; Mateos MV
    Blood; 2015 May; 125(20):3069-75. PubMed ID: 25838344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The road to treating smoldering multiple myeloma.
    Korde N; Mailankody S; Landgren O
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S59-64. PubMed ID: 25486957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Smoldering multiple myeloma].
    Fouquet G; Guidez S; Herbaux C; Demarquette H; Leleu X
    Rev Med Interne; 2014 Apr; 35(4):243-9. PubMed ID: 24050785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?
    Fawole A; Abonour R; Stender M; Shatavi S; Gaikazian S; Anderson J; Jaiyesimi I
    Leuk Lymphoma; 2015 Jan; 56(1):34-41. PubMed ID: 24564573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.
    Muchtar E; Kumar SK; Magen H; Gertz MA
    Leuk Lymphoma; 2018 Feb; 59(2):288-299. PubMed ID: 28592156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to smoldering myeloma.
    Mateos MV; San Miguel JF
    Curr Hematol Malig Rep; 2013 Dec; 8(4):270-6. PubMed ID: 23975678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of asymptomatic myeloma.
    Mateos MV
    Curr Opin Oncol; 2014 Nov; 26(6):670-6. PubMed ID: 25210868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.
    Waxman AJ; Kuehl M; Balakumaran A; Weiss B; Landgren O
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):248-57. PubMed ID: 20709660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies.
    Kazandjian D; Mailankody S; Korde N; Landgren O
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):578-87. PubMed ID: 25654479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoldering multiple myeloma: to treat or not to treat.
    Gentile M; Offidani M; Vigna E; Corvatta L; Recchia AG; Morabito L; Martino M; Morabito F; Gentili S
    Expert Opin Pharmacother; 2015 Apr; 16(6):785-90. PubMed ID: 25659943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
    Sørrig R; Klausen TW; Salomo M; Vangsted AJ; Østergaard B; Gregersen H; Frølund UC; Andersen NF; Helleberg C; Andersen KT; Pedersen RS; Pedersen P; Abildgaard N; Gimsing P;
    Eur J Haematol; 2016 Sep; 97(3):303-9. PubMed ID: 26710662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoldering multiple myeloma: when to observe and when to treat?
    Mateos MV; San Miguel JF
    Am Soc Clin Oncol Educ Book; 2015; ():e484-92. PubMed ID: 25993213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The consultant's guide to smoldering multiple myeloma.
    Thorsteinsdottir S; Kristinsson SY
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):551-559. PubMed ID: 36485144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
    Bianchi G; Anderson KC
    CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing treatment for smoldering myeloma: is earlier better?
    Hernández JÁ; Martínez-López J; Lahuerta JJ
    Expert Rev Hematol; 2019 May; 12(5):345-354. PubMed ID: 30907176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoldering multiple myeloma.
    Gao M; Yang G; Kong Y; Wu X; Shi J
    Biomed Res Int; 2015; 2015():623254. PubMed ID: 26000300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.